First AI-Crafted Universal Coronavirus Vaccine Passes Early Human Trial

Researchers in the United Kingdom have tested a new vaccine designed entirely by artificial intelligence. It uses a super antigen built from shared features across multiple coronaviruses to trigger broad immune protection. The trial at two UK hospitals involved 39 healthy volunteers. Early results published in a medical journal show the shot was safe and sparked immune responses against SARS-CoV-2, SARS, and related bat coronaviruses. Developed by scientists at a leading university and its biotech spin-out, the DNA-based vaccine is delivered via a needle-free microfluidic jet. Experts say this marks a shift from reactive to proactive pandemic planning, though larger Phase 2 studies are still needed.

Use The App To Win ₦1m

Stories are shared by community members. This article does not represent the official view of NaijaWorld — the author is solely responsible for its content.